Avanir Pharmaceuticals Inc it agreed to be acquired by a unit of Japan's Otsuka Holdings Co Ltd for about $3.5 billion. Otsuka Pharmaceutical Co Ltd will pay $17 per share in cash, representing a premium of 13.3 percent to Avanir's stock close on Monday.
AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. Shares of AVNR traded higher by 0.54% or $0.08/share to $15.00. In the past year, the shares have traded as low as $2.62 and as high as $15.34. On average, 6152350 shares of AVNR exchange hands on a given day and today's volume is recorded at 3097228.
Source
